FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048235511> ?p ?o ?g. }

• W2048235511 endingPage "440" @default.
• W2048235511 startingPage "435" @default.
• W2048235511 abstract "Overactivity of the brain renin-angiotensin system (RAS) has been implicated in the development and maintenance of hypertension in several experimental animal models. We have recently reported that, in the murine brain RAS, angiotensin II (AngII) is converted by aminopeptidase A (APA) into angiotensin III (AngIII), which is itself degraded by aminopeptidase N (APN), both peptides being equipotent to increase vasopressin release and arterial blood pressure when injected by the intracerebroventricular (i.c.v.) route. Because AngII is converted in vivo into AngIII, the exact nature of the active peptide is not precisely known. To delineate their respective roles in the central control of cardiovascular functions, specific and selective APA and APN inhibitors are needed to block the metabolic pathways of AngII and AngIII respectively. In the absence of such compounds for APA, we first explored the organization of the APA active site by site-directed mutagenesis. This led us to propose a molecular mechanism of action for APA similar to that proposed for the bacterial enzyme thermolysin deduced from X-ray diffraction studies. Secondly, we developed a specific and selective APA inhibitor, compound EC33 [(S)-3-amino-4-mercaptobutylsulphonic acid], as well as a potent and selective APN inhibitor, PC18 (2-amino-4-methylsulphonylbutane thiol). With these new tools we examined the respective roles of AngII and AngIII in the central control of arterial blood pressure. A central blockade of APA with the APA inhibitor EC33 suppressed the pressor effect of exogenous AngII, suggesting that brain AngII must be converted into AngIII to increase arterial blood pressure. Furthermore, EC33, injected alone i.c.v. but not intravenously, caused a dose-dependent decrease in arterial blood pressure by blocking the formation of brain AngIII but not systemic AngIII. This is corroborated by the fact that the selective APN inhibitor PC 18 administered alone via the i.c.v. route increased arterial blood pressure. This pressor response was blocked by prior treatment with the angiotensin type 1 receptor antagonist losartan, showing that blocking the action of APN on AngIII metabolism leads to an increase in endogenous AngIII levels, resulting in arterial blood pressure increase through an interaction with angiotensin type 1 receptors. These results demonstrate that AngIII is a major effector peptide of the brain RAS, exerting a tonic stimulatory control over arterial blood pressure. Thus APA, the enzyme responsible for the formation of brain AngIII, represents a potential central therapeutic target that justifies the development of APA inhibitors, crossing the blood-brain barrier, as central anti-hypertensive agents." @default.
• W2048235511 created "2016-06-24" @default.
• W2048235511 creator A5011338417 @default.
• W2048235511 creator A5028890054 @default.
• W2048235511 creator A5035706117 @default.
• W2048235511 creator A5050276303 @default.
• W2048235511 creator A5069996257 @default.
• W2048235511 creator A5070519498 @default.
• W2048235511 creator A5074665989 @default.
• W2048235511 creator A5084962841 @default.
• W2048235511 date "2000-08-01" @default.
• W2048235511 modified "2023-10-18" @default.
• W2048235511 title "Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure" @default.
• W2048235511 doi "https://doi.org/10.1042/bst0280435" @default.
• W2048235511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10961935" @default.
• W2048235511 hasPublicationYear "2000" @default.
• W2048235511 type Work @default.
• W2048235511 sameAs 2048235511 @default.
• W2048235511 citedByCount "39" @default.
• W2048235511 countsByYear W20482355112013 @default.
• W2048235511 countsByYear W20482355112014 @default.
• W2048235511 countsByYear W20482355112015 @default.
• W2048235511 countsByYear W20482355112016 @default.
• W2048235511 countsByYear W20482355112017 @default.
• W2048235511 countsByYear W20482355112018 @default.
• W2048235511 countsByYear W20482355112020 @default.
• W2048235511 countsByYear W20482355112021 @default.
• W2048235511 countsByYear W20482355112022 @default.
• W2048235511 crossrefType "journal-article" @default.
• W2048235511 hasAuthorship W2048235511A5011338417 @default.
• W2048235511 hasAuthorship W2048235511A5028890054 @default.
• W2048235511 hasAuthorship W2048235511A5035706117 @default.
• W2048235511 hasAuthorship W2048235511A5050276303 @default.
• W2048235511 hasAuthorship W2048235511A5069996257 @default.
• W2048235511 hasAuthorship W2048235511A5070519498 @default.
• W2048235511 hasAuthorship W2048235511A5074665989 @default.
• W2048235511 hasAuthorship W2048235511A5084962841 @default.
• W2048235511 hasConcept C104849204 @default.
• W2048235511 hasConcept C126322002 @default.
• W2048235511 hasConcept C134018914 @default.
• W2048235511 hasConcept C150903083 @default.
• W2048235511 hasConcept C170493617 @default.
• W2048235511 hasConcept C185592680 @default.
• W2048235511 hasConcept C198710026 @default.
• W2048235511 hasConcept C207001950 @default.
• W2048235511 hasConcept C2776580952 @default.
• W2048235511 hasConcept C2780985610 @default.
• W2048235511 hasConcept C2908560794 @default.
• W2048235511 hasConcept C2908929049 @default.
• W2048235511 hasConcept C515207424 @default.
• W2048235511 hasConcept C55493867 @default.
• W2048235511 hasConcept C71924100 @default.
• W2048235511 hasConcept C84393581 @default.
• W2048235511 hasConcept C86803240 @default.
• W2048235511 hasConcept C98274493 @default.
• W2048235511 hasConceptScore W2048235511C104849204 @default.
• W2048235511 hasConceptScore W2048235511C126322002 @default.
• W2048235511 hasConceptScore W2048235511C134018914 @default.
• W2048235511 hasConceptScore W2048235511C150903083 @default.
• W2048235511 hasConceptScore W2048235511C170493617 @default.
• W2048235511 hasConceptScore W2048235511C185592680 @default.
• W2048235511 hasConceptScore W2048235511C198710026 @default.
• W2048235511 hasConceptScore W2048235511C207001950 @default.
• W2048235511 hasConceptScore W2048235511C2776580952 @default.
• W2048235511 hasConceptScore W2048235511C2780985610 @default.
• W2048235511 hasConceptScore W2048235511C2908560794 @default.
• W2048235511 hasConceptScore W2048235511C2908929049 @default.
• W2048235511 hasConceptScore W2048235511C515207424 @default.
• W2048235511 hasConceptScore W2048235511C55493867 @default.
• W2048235511 hasConceptScore W2048235511C71924100 @default.
• W2048235511 hasConceptScore W2048235511C84393581 @default.
• W2048235511 hasConceptScore W2048235511C86803240 @default.
• W2048235511 hasConceptScore W2048235511C98274493 @default.
• W2048235511 hasIssue "4" @default.
• W2048235511 hasLocation W20482355111 @default.
• W2048235511 hasLocation W20482355112 @default.
• W2048235511 hasOpenAccess W2048235511 @default.
• W2048235511 hasPrimaryLocation W20482355111 @default.
• W2048235511 hasRelatedWork W1989328696 @default.
• W2048235511 hasRelatedWork W2002499589 @default.
• W2048235511 hasRelatedWork W2016647631 @default.
• W2048235511 hasRelatedWork W2042660006 @default.
• W2048235511 hasRelatedWork W2054149954 @default.
• W2048235511 hasRelatedWork W2077998387 @default.
• W2048235511 hasRelatedWork W2116067399 @default.
• W2048235511 hasRelatedWork W2126797993 @default.
• W2048235511 hasRelatedWork W2172198736 @default.
• W2048235511 hasRelatedWork W2621160379 @default.
• W2048235511 hasVolume "28" @default.
• W2048235511 isParatext "false" @default.
• W2048235511 isRetracted "false" @default.
• W2048235511 magId "2048235511" @default.
• W2048235511 workType "article" @default.